Glycoproteins contribute to tumor growth by facilitating cell proliferation and protecting cancer cells from apoptosis (programmed cell death). For instance, glycoproteins like EGFR and HER2 are overexpressed in certain cancers and are involved in signaling pathways that promote cell division and survival. Targeting these glycoproteins with specific therapies can help to curb tumor growth.